Gerloni Mara, Zanetti Maurizio
The Laboratory of Immunology, Department of Medicine and Cancer Center, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0837, USA.
Springer Semin Immunopathol. 2005 Jun;27(1):37-48. doi: 10.1007/s00281-004-0193-z. Epub 2005 Mar 15.
T cell immunity is the key to protective immune responses against tumors. Traditionally, this function has been ascribed to CD8 T lymphocytes with cytotoxic activity, which are restricted by MHC class I molecules. In recent years the realization that CD4 T cells can also play a relevant role in protective anti-tumor responses has received growing attention. Here we will discuss the role of MHC class II-restricted T cells in response to, and in the regulation of, tumor antigens. Emphasis will be placed on four areas: (1) the role of CD4 T cell immunity in tumor protection in animal models and putative mode of action, (2) tumor antigens recognized by human CD4 T cells, (3) the cooperation between two CD4 T cells of different specificity as a new way to jump start the response against sub-immunogenic determinants of tumor antigens in a tolerant environment, and (4) the negative impact of regulatory CD4 T cells on anti-tumor T cell responses. By drawing attention to these four areas, it is our intention to provide the reader with a comprehensive view of issues of contemporary importance for this field, in the expectation that the information will help a better design of therapeutic cancer vaccines.
T细胞免疫是针对肿瘤的保护性免疫反应的关键。传统上,这种功能归因于具有细胞毒性活性的CD8 T淋巴细胞,它们受MHC I类分子的限制。近年来,CD4 T细胞在保护性抗肿瘤反应中也能发挥相关作用这一认识受到越来越多的关注。在此,我们将讨论MHC II类限制性T细胞在应答肿瘤抗原及调节肿瘤抗原方面的作用。重点将放在四个方面:(1)CD4 T细胞免疫在动物模型肿瘤保护中的作用及假定的作用方式,(2)人类CD4 T细胞识别的肿瘤抗原,(3)不同特异性的两种CD4 T细胞之间的合作,作为在耐受环境中启动针对肿瘤抗原亚免疫原性决定簇反应的一种新方式,以及(4)调节性CD4 T细胞对抗肿瘤T细胞反应的负面影响。通过关注这四个方面,我们旨在为读者提供该领域当代重要问题的全面观点,期望这些信息有助于更好地设计治疗性癌症疫苗。